United States Pharmaceuticals Market 規模およびシェア分析 - 成長トレンドおよび予測 (2023 - 2030)

United States Pharmaceuticals Market is Segmented By Product Type (Prescription Drugs, Generic Drugs, OTC Drugs, Biologics, Biosimilars), By Therapy Area (Oncology, Diabetes, Autoimmune Diseases, Neurological Disorders, Cardiovascular, Infectious Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Route of Administration (Oral, Parenteral, Topical), By End User (Hospitals, Clinics, Homecare Settings). The report offers the value (in USD billion) for the above-mentioned segments.

Competitive overview of United States Pharmaceuticals Market

米国医薬品市場で動作する主要なプレーヤーは、ジョンソン社とジョンソン社、Pfizer Inc.、AbbVie Inc.、Merck KGaA、Bristol-Myers Squibb Company、Amgen Inc.、Eli Lilly、Company、Novatis AG、Gilead Sciences、Inc.、F. Hoffmann-La Roche Ltd、Sanofi、AstraZeneca、GSK plc。、Bayer AG、Boehring Ingelheim International GmbH、Avgen社、Avgen社

United States Pharmaceuticals Market Leaders

  • ジョンソン・アンド・ジョンソン株式会社
  • 株式会社Pfizer
  • 株式会社AbbVie
  • メルク KGaA
  • ブリストル・マイアーズ・スクイブ・カンパニー
*Disclaimer: Major players are listed in no particular order.

United States Pharmaceuticals Market - Competitive Rivalry, 2023

Market Concentration Graph

United States Pharmaceuticals Market

Market Consolidated
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
*Source: Coherent Market Insights